The impact of contrast enhancement reduction on tumor response in patients with advanced renal cell carcinoma that treated with presurgical targeting therapy.

2016 ◽  
Vol 34 (2_suppl) ◽  
pp. 510-510
Author(s):  
Shingo Hatakeyama ◽  
Takahiro Yoneyama ◽  
Yasuhiro Hashimoto ◽  
Takuya Koie ◽  
Chikara Ohyama
Keyword(s):  
Targeted Therapy ◽  
Contrast Enhancement ◽  
Distant Metastasis ◽  
Mtor Inhibitor ◽  
Tumor Response ◽  
Tumor Shrinkage ◽  
Targeting Therapy ◽  
Tumor Reduction ◽  
Presurgical Therapy ◽  
The Impact

510 Background: RECIST is a standard tool for tumor response assessment. However, evaluation for targeted therapy by RECIST is insensitive because tumors often showed a modest change in size despite of significant necrosis. Therefore, we investigated an impact of contrast enhancement reduction for tumor shrinkage in RCC patients with presurgical targeting therapy. Methods: From March 2011 to July 2015, 17 patients (18 tumors) with RCC who underwent presurgical targeting therapy were included. Indications for presurgical targeting therapy were cT3-4, bilateral tumors, poor performance status, or small distant metastasis. Contrast enhancement reduction was evaluated by contrast medium enhanced area (CMEA) before and after targeting therapy. CMEA measurements were performed by OsiriX and Adobe Photoshop. Eighteen tumors were evaluated by RECIST and CMEA. Differences between two methods were compared. Results: Median age and followup after initiation of targeted therapy were 68 years old and 15.3 months. IVC thrombus and small distant metastasis existed in seven (41%) and five (29%) patents, respectively. Fifteen patients (88%) received TKI based (sunitinib and/or axitinib), and three patients (12%) received mTOR inhibitor based (everolimus or temsirolimus) presurgical therapy. The median treatment period of presurgical targeted therapy was 3.3 months. Median tumor responses in RECIST and CMEA were 10.5% and 49.0%, that was significantly correlated by liner regression analysis (P = 0.002). TKI based presurgical therapy showed significant tumor reduction in CMEA than RECIST (P = 0.0062). In addition, tumor reduction rate was significantly higher in TKI based presurgical therapy than mTOR inhibitor (P = 0.014). No patient experienced tumor recurrence. Conclusions: Contrast enhancement reduction might be useful tool for tumor shrinkage in patients with RCC who underwent presurgical targeting therapy.

scholarly journals Surgical choice of non-small cell lung cancer with unexpected pleural dissemination intraoperatively

BMC Cancer ◽  
2021 ◽  
Vol 21 (1) ◽  
Author(s):  
Junjie Hu ◽  
Yan Chen ◽  
Xinsheng Zhu ◽  
Qiang Ma ◽  
Jing Zhang ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Targeted Therapy ◽  
Small Cell Lung Cancer ◽  
Distant Metastasis ◽  
Survival Benefit ◽  
Tumor Resection ◽  
Small Cell ◽  
Small Cell Lung ◽  
Systematic Lymphadenectomy ◽  
Cox Analysis

Abstract Background Whether patients with non-small cell lung cancer (NSCLC) with unexpected pleural dissemination (UPD) could get survival benefit from tumor resection remained controversial. Methods Totally, 169 patients with NSCLC with UPD were included between 2012 and 2016. Patients were divided into the tumor resection and open-close group. Progression-free survival (PFS) and overall survival (OS) were compared with a log-rank test. The multivariable Cox analysis was applied to identify prognostic factors. Results Sixty-five patients received open-close surgery and 104 patients underwent main tumor and visible pleural nodule resection. Tumor resection significantly prolonged OS (hazard ratio [HR]: 0.408, P < 0.001), local PFS (HR: 0.283, P < 0.001), regional PFS (HR: 0.506, P = 0.005), and distant metastasis (HR: 0.595, P = 0.032). Multivariable Cox analysis confirmed that surgical method was an independent prognostic factor for OS, local PFS and regional PFS, except distant metastasis. Subgroup analyses indicated that tumor resection could not improve OS in the patients who received targeted therapy (HR: 0.649, P = 0.382), however, tumor resection was beneficial for the patients who received adjuvant chemotherapy alone (HR: 0.322, P < 0.001). In the tumor resection group, lobectomy (HR: 0.960, P = 0.917) and systematic lymphadenectomy (HR: 1.512, P = 0.259) did not show survival benefit for OS. Conclusions Main tumor and visible pleural nodule resection could improve prognosis in patients with UPD who could not receive adjuvant targeted therapy. Sublobar resection without systematic lymphadenectomy may be the optimal procedure.

Aberrant protein glycosylation in cancer: implications in targeted therapy

2021 ◽  
Author(s):  
Joana G. Rodrigues ◽  
Henrique O. Duarte ◽  
Celso A. Reis ◽  
Joana Gomes
Keyword(s):  
Targeted Therapy ◽  
Tumour Cell ◽  
Rational Design ◽  
Molecular Mechanisms ◽  
Clinical Performance ◽  
Therapeutic Strategies ◽  
Protein Glycosylation ◽  
Immune Checkpoints ◽  
Immunosuppressive Microenvironment ◽  
The Impact

Aberrant cell surface glycosylation signatures are currently known to actively drive the neoplastic transformation of healthy cells. By disrupting the homeostatic functions of their protein carriers, cancer-associated glycans mechanistically underpin several molecular hallmarks of human malignancy. Furthermore, such aberrant glycan structures play key roles in the acquisition of molecular resistance to targeted therapeutic agents, which compromises their clinical efficacy, by modulating tumour cell aggressiveness and supporting the establishment of an immunosuppressive microenvironment. Recent advances in the study of the tumour cell glycoproteome have unravelled previously elusive molecular mechanisms of therapeutic resistance, guided the rational design of novel personalized therapeutic strategies, and may further improve the clinical performance of currently approved anti-cancer targeted agents. In this review, we highlight the impact of glycosylation in cancer targeted therapy, with particular focus on receptor tyrosine kinase-targeted therapy, immune checkpoints blockade therapy, and current developments on therapeutic strategies directed to glycan-binding proteins and other innovative glycan therapeutic strategies.

scholarly journals Challenges in UAS-Based TIR Imagery Processing: Image Alignment and Uncertainty Quantification

2020 ◽  
Vol 12 (10) ◽  
pp. 1552 ◽  
Author(s):  
Veronika Döpper ◽  
Tobias Gränzig ◽  
Birgit Kleinschmit ◽  
Michael Förster
Keyword(s):  
Land Cover ◽  
Contrast Enhancement ◽  
Camera Calibration ◽  
Weather Conditions ◽  
Thermal Infrared ◽  
Temperature Correction ◽  
Image Alignment ◽  
Data Sets ◽  
Image Contrast Enhancement ◽  
The Impact

Thermal infrared measurements acquired with unmanned aerial systems (UAS) allow for high spatial resolution and flexibility in the time of image acquisition to assess ground surface temperature. Nevertheless, thermal infrared cameras mounted on UAS suffer from low radiometric accuracy as well as low image resolution and contrast hampering image alignment. Our analysis aims to determine the impact of the sun elevation angle (SEA), weather conditions, land cover, image contrast enhancement, geometric camera calibration, and inclusion of yaw angle information and generic and reference pre-selection methods on the point cloud and number of aligned images generated by Agisoft Metashape. We, therefore, use a total amount of 56 single data sets acquired on different days, times of day, weather conditions, and land cover types. Furthermore, we assess camera noise and the effect of temperature correction based on air temperature using features extracted by structure from motion. The study shows for the first time generalizable implications on thermal infrared image acquisitions and presents an approach to perform the analysis with a quality measure of inter-image sensor noise. Better image alignment is reached for conditions of high contrast such as clear weather conditions and high SEA. Alignment can be improved by applying a contrast enhancement and choosing both, reference and generic pre-selection. Grassland areas are best alignable, followed by cropland and forests. Geometric camera calibration hampers feature detection and matching. Temperature correction shows no effect on radiometric camera uncertainty. Based on a valid statistical analysis of the acquired data sets, we derive general suggestions for the planning of a successful field campaign as well as recommendations for a suitable preprocessing workflow.

Sign in / Sign up

Export Citation Format

Share Document